![Glenn L. Cooper](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Glenn L. Cooper
Voorzitter bij
Lascaux Media LLC
Profiel
Glenn L.
Cooper is currently the Chairman of Lascaux Media LLC.
He previously served as the Chairman & CEO of Indevus Pharmaceuticals, Inc. from 1996 to 2009, President & CEO of Progenitor, Inc. from 1992 to 1994, Executive Chairman of Fortress Biotech, Inc. from 2012 to 2013, Independent Director of Repligen Corp.
from 2009 to 2020, and Independent Director of Gentium Srl from 2009 to 2013.
He also served as the Director of Clinical Research at Lilly Research Center Ltd. from 1987 to 1990.
Additionally, he was the COO & Executive VP of Sphinx Pharmaceuticals Corp.
Dr. Cooper received his undergraduate degree from Harvard College and his doctorate from Tufts University School of Medicine.
Actieve functies van Glenn L. Cooper
| Bedrijven | Functie | Begin |
|---|---|---|
Lascaux Media LLC | Voorzitter | - |
Eerdere bekende functies van Glenn L. Cooper
| Bedrijven | Functie | Einde |
|---|---|---|
| REPLIGEN CORPORATION | Directeur/Bestuurslid | 13-05-2020 |
| GENTIUM S.P.A. (ADR) | Directeur/Bestuurslid | 27-03-2013 |
| FORTRESS BIOTECH, INC. | Algemeen Directeur | 01-04-2011 |
Indevus Pharmaceuticals, Inc.
 Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical compounds for urology, gynecology, and infectious diseases | Algemeen Directeur | 01-01-2009 |
Progenitor, Inc.
 Progenitor, Inc. BiotechnologyHealth Technology Develops pharmaceutical compounds for nervous system | President | 01-06-1994 |
Opleiding van Glenn L. Cooper
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
57
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Indevus Pharmaceuticals, Inc.
Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical compounds for urology, gynecology, and infectious diseases | Health Technology |
Repligen Corp.
 Repligen Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures biologic drugs | Health Technology |
Progenitor, Inc.
Progenitor, Inc. BiotechnologyHealth Technology Develops pharmaceutical compounds for nervous system | Health Technology |
Gentium Srl
 Gentium Srl Pharmaceuticals: MajorHealth Technology Manufactures and develops biopharmaceutical products for cancer treatments & vascular diseases | Health Technology |
Fortress Biotech, Inc.
 Fortress Biotech, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and biotechnology products | Health Technology |
Sphinx Pharmaceuticals Corp
 Sphinx Pharmaceuticals Corp Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
Lilly Research Center Ltd.
 Lilly Research Center Ltd. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly Research Center Ltd. is a British company. | Health Technology |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lascaux Media LLC | |
Tufts University School of Medicine
 Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
